| Literature DB >> 30633430 |
Dea Siggaard Stenbaek1,2,3, Sara Kristiansen1,2,3, Daniel Burmester1,2,3, Martin Korsbak Madsen1,2,3, Vibe Gedsoe Frokjaer1,2,3, Gitte Moos Knudsen1,2,3, Patrick MacDonald Fisher1,2,3.
Abstract
Recent research found lasting increases in personality trait Openness in healthy individuals and patients after administration of the serotonin 2A receptor (5-HT2A R) agonist psilocybin. However, no studies have investigated whether 5-HT2A R availability as imaged using positron emission tomography (PET) is associated with this trait. In 159 healthy individuals (53 females), the association between 5-HT2A R binding in neocortex imaged with [18 F]altanserin or [11 C]Cimbi-36 PET and personality trait Openness was investigated using linear regression models. In these models the influence of sex on the association was also investigated. Trait Openness was assessed with the NEO Personality Inventory-Revised. No significant associations between neocortical 5-HT2A R binding and trait Openness were found for [18 F]altanserin (p = 0.5) or [11 C]Cimbi-36 (p = 0.8). Pooling the data in a combined model did not substantially change our results (p = 0.4). No significant interactions with sex were found (p > 0.35). Our results indicate that differences in 5-HT2A R availability are not related to variations in trait Openness in healthy individuals. Although stimulation of the 5-HT2A R with compounds such as psilocybin may contribute to long-term changes in trait Openness, there is no evidence in favor of an association between 5-HT2A R and trait Openness.Entities:
Keywords: 5-HT2A; NEO personality inventory; PET scan; [11C]Cimbi-36; [18F]altanserin; biomarkers; personality; serotonin; trait Openness
Mesh:
Substances:
Year: 2019 PMID: 30633430 PMCID: PMC6865516 DOI: 10.1002/hbm.24511
Source DB: PubMed Journal: Hum Brain Mapp ISSN: 1065-9471 Impact factor: 5.038